Buy DCTH by Sep 29, 2028.

​ I recently started a position in DCTH (Delcath Systems) and would love to hear from people who follow the company or the biotech/medtech space. A few things caught my attention: \- The company already has revenue, so this isn't simply a pre-revenue biotech depending on a single clinical trial or binary outcome. \- They have an interesting technology/research platform focused on liver cancer, which I find particularly compelling given how difficult certain liver cancers are to treat. \- I …